Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc. > A half cent at a time
View:
Post by rjc7 on Apr 22, 2024 7:52am

A half cent at a time

They slowly push this thing down
Comment by wizzdumb on Apr 22, 2024 11:24am
What else is new? Uncontrollable by management team, even with buyback. The company is in great shape, with future opportunities galore. Will be another great quarter on way to another record. Be thankful you can still buy more at a crazy discount, which is what I do. Our time will come, and when it does it will move upwards very quickly. This one definitely tests one's patience, but I don' ...more  
Comment by prophetoffactz on Apr 22, 2024 12:04pm
The S&P Biotech Index is down over 20% from its high of less than two months ago putting it in a new bear market. Interest rates have been climbing and that is not good for the sector.
Comment by rjc7 on Apr 22, 2024 7:43pm
I'm not convinced the Index, nor interest rates, nor a bear market has any bearing on such a small cap company. This is strictly a relatively unknown company with great upside and too many short term traders.  Sad.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities